PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. (2019)
Attributed to:
Gene therapy for refractory epilepsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ana.25524
PubMed Identifier: 31187503
Publication URI: http://europepmc.org/abstract/MED/31187503
Type: Journal Article/Review
Volume: 86
Parent Publication: Annals of neurology
Issue: 2
ISSN: 0364-5134